Kelsey Stephen Michael sold $652K of RVMD
Kelsey Stephen Michael (See Remarks) sold 4,175 shares of Revolution Medicines, Inc. (RVMD) at $156.12 ($0.65M total) on 2026-06-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale quantity, price, and post-transaction holdings, but it does not introduce new company fundamentals.
Market read
Traders may note the insider sale, but the 10b5-1 framing reduces the likelihood of a fundamental repricing catalyst.
What to watch
The article provides only the sale details; it does not state whether other insiders sold, whether the plan is part of scheduled diversification, or whether there were concurrent company catalysts.
Background
The article is a SEC Form 4 insider transaction disclosure for Revolution Medicines, Inc.
Ticker impact
Revolution Medicines insider Kelsey Stephen Michael sold 4,175 shares on 2026-06-16 at $156.1192, per a filed Form 4.
Likely minimal immediate price impact; any effect is more about sentiment than new company information.
The filing discloses a Form 4 transaction size and price, but it does not include new operational, clinical, regulatory, or financial guidance.
Market effects
No clear sector read-through because the disclosure is an insider sale without accompanying company-specific catalyst.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, traders sometimes treat repeated insider selling as a weak sentiment signal, especially if it coincides with other negative developments not mentioned here.
Key entities
- issuerRevolution Medicines, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderKelsey Stephen Michael
Officer who sold shares under a pre-arranged 10b5-1 plan.
